A Study to Evaluate Safinamide's Effect on Dopamine and Serotonin's Availability by Using Brain Imaging
Clinical trial NCT01264861 · TERMINATED
Trial details
- NCT number
- NCT01264861
- Sponsor
- Newron Pharmaceuticals SPA
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-01
- Primary completion
- 2012-01-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.